Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,092)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Auna SA | AUNA | $5.41 | $400.64M | 90.2 | — |
| Capricor Therapeutics, Inc. | CAPR | $5.88 | $400.00M | — | |
| Community Health Systems, Inc. | CYH | $2.82 | $397.65M | 1.5 | — |
| Zura Bio Limited | ZURA | $4.13 | $395.77M | — | |
| Carlsmed, Inc. | CARL | $14.31 | $395.07M | — | |
| Orthofix Medical Inc. | OFIX | $9.74 | $393.71M | — | |
| Claritev Corporation | CTEV | $23.00 | $389.79M | — | |
| Editas Medicine, Inc. | EDIT | $2.51 | $385.49M | — | |
| Embecta Corp. | EMBC | $6.68 | $378.49M | 4.5 | 0.62% |
| Viemed Healthcare, Inc. | VMD | $9.75 | $371.36M | 27.1 | — |
| Scribe Therapeutics Inc. | SCTX | $19.30 | $365.38M | — | |
| Fennec Pharmaceuticals Inc. Common Stock | FENC | $10.38 | $364.00M | — | |
| CapsoVision, Inc. | CV | $6.80 | $361.83M | — | |
| Kyverna Therapeutics, Inc. | KYTX | $5.84 | $361.17M | — | |
| Rezolute, Inc. | RZLT | $3.70 | $357.87M | — | |
| Orchestra BioMed Holdings, Inc. | OBIO | $5.81 | $348.91M | — | |
| Auxly Cannabis Group Inc. | XLY.TO | CA$3.36 | CA$346.87M | 14.0 | — |
| Nautilus Biotechnology, Inc. | NAUT | $2.71 | $344.86M | — | |
| Relmada Therapeutics, Inc. | RLMD | $3.21 | $342.41M | — | |
| Opus Genetics, Inc. | IRD | $4.12 | $342.35M | — | |
| Galectin Therapeutics Inc. | GALT | $3.37 | $339.86M | — | |
| Cipher Pharmaceuticals Inc. | CPH.TO | CA$13.31 | CA$338.27M | 8.7 | — |
| Enanta Pharmaceuticals, Inc. | ENTA | $11.31 | $329.41M | — | |
| Atea Pharmaceuticals, Inc. | AVIR | $4.08 | $327.24M | — | |
| C4 Therapeutics, Inc. | CCCC | $3.17 | $321.10M | — | |
| Mobia Medical, Inc. | MOBI | $9.64 | $320.93M | — | |
| Spectral Medical Inc. | EDT.TO | CA$1.09 | CA$319.97M | — | |
| Emergent BioSolutions Inc. | EBS | $6.20 | $317.89M | — | |
| Artiva Biotherapeutics, Inc. | ARTV | $6.49 | $317.30M | — | |
| Arcturus Therapeutics Holdings Inc. | ARCT | $11.07 | $314.64M | — | |
| Contineum Therapeutics, Inc. | CTNM | $8.35 | $314.14M | — | |
| Alpha Teknova, Inc. | TKNO | $5.85 | $314.08M | — | |
| Turn Therapeutics Inc. | TTRX | $10.15 | $308.23M | — | |
| Vogenx, Inc. | VOGX | $20.39 | $302.90M | — | |
| Sanara MedTech Inc. | SMTI | $32.77 | $301.09M | — | |
| ClearPoint Neuro, Inc. | CLPT | $9.25 | $299.25M | — | |
| X4 Pharmaceuticals, Inc. | XFOR | $3.01 | $298.43M | — | — |
| Surrozen, Inc. | SRZN | $25.32 | $297.60M | — | |
| Benitec Biopharma Inc. | BNTC | $8.50 | $295.11M | — | |
| Profound Medical Corp. | PRN.TO | CA$8.03 | CA$293.42M | — | |
| Century Therapeutics, Inc. | IPSC | $1.61 | $291.53M | — | |
| Prelude Therapeutics Incorporated | PRLD | $3.65 | $291.28M | — | |
| Agenus Inc. | AGEN | $6.40 | $289.04M | 2.5 | — |
| Cabaletta Bio, Inc. | CABA | $1.54 | $286.53M | — | |
| Fulcrum Therapeutics, Inc. | FULC | $3.70 | $282.61M | — | |
| InfuSystem Holdings, Inc. | INFU | $14.05 | $279.84M | 35.1 | — |
| Ocugen, Inc. | OCGN | $0.82 | $276.41M | — | |
| Anika Therapeutics, Inc. | ANIK | $20.60 | $275.69M | — | |
| Treace Medical Concepts, Inc. | TMCI | $4.14 | $269.24M | — | |
| Quantum-Si incorporated | QSI | $1.23 | $269.23M | — |
Auna SA
Healthcare / Medical Care Facilities
- Market Cap
- $400.64M
- P/E
- 90.2
Capricor Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $400.00M
- P/E
- unprofitable
Community Health Systems, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $397.65M
- P/E
- 1.5
Zura Bio Limited
Healthcare / Biotechnology
- Market Cap
- $395.77M
- P/E
- unprofitable
Carlsmed, Inc.
Healthcare / Health Information Services
- Market Cap
- $395.07M
- P/E
- unprofitable
Orthofix Medical Inc.
Healthcare / Medical Devices
- Market Cap
- $393.71M
- P/E
- unprofitable
Claritev Corporation
Healthcare / Health Information Services
- Market Cap
- $389.79M
- P/E
- unprofitable
Editas Medicine, Inc.
Healthcare / Biotechnology
- Market Cap
- $385.49M
- P/E
- unprofitable
Embecta Corp.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $378.49M
- P/E
- 4.5
- Dividend Yield
- 0.62%
Viemed Healthcare, Inc.
Healthcare / Medical Devices
- Market Cap
- $371.36M
- P/E
- 27.1
Scribe Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $365.38M
- P/E
- unprofitable
Fennec Pharmaceuticals Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $364.00M
- P/E
- unprofitable
CapsoVision, Inc.
Healthcare / Medical Devices
- Market Cap
- $361.83M
- P/E
- unprofitable
Kyverna Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $361.17M
- P/E
- unprofitable
Rezolute, Inc.
Healthcare / Biotechnology
- Market Cap
- $357.87M
- P/E
- unprofitable
Orchestra BioMed Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $348.91M
- P/E
- unprofitable
Auxly Cannabis Group Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$346.87M
- P/E
- 14.0
Nautilus Biotechnology, Inc.
Healthcare / Biotechnology
- Market Cap
- $344.86M
- P/E
- unprofitable
Relmada Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $342.41M
- P/E
- unprofitable
Opus Genetics, Inc.
Healthcare / Biotechnology
- Market Cap
- $342.35M
- P/E
- unprofitable
Galectin Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $339.86M
- P/E
- unprofitable
Cipher Pharmaceuticals Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$338.27M
- P/E
- 8.7
Enanta Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $329.41M
- P/E
- unprofitable
Atea Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $327.24M
- P/E
- unprofitable
C4 Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $321.10M
- P/E
- unprofitable
Mobia Medical, Inc.
Healthcare / Medical Devices
- Market Cap
- $320.93M
- P/E
- unprofitable
Spectral Medical Inc.
Healthcare / Diagnostics & Research
- Market Cap
- CA$319.97M
- P/E
- unprofitable
Emergent BioSolutions Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $317.89M
- P/E
- unprofitable
Artiva Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $317.30M
- P/E
- unprofitable
Arcturus Therapeutics Holdings Inc.
Healthcare / Biotechnology
- Market Cap
- $314.64M
- P/E
- unprofitable
Contineum Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $314.14M
- P/E
- unprofitable
Alpha Teknova, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $314.08M
- P/E
- unprofitable
Turn Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $308.23M
- P/E
- unprofitable
Vogenx, Inc.
Healthcare / Biotechnology
- Market Cap
- $302.90M
- P/E
- unprofitable
Sanara MedTech Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $301.09M
- P/E
- unprofitable
ClearPoint Neuro, Inc.
Healthcare / Medical Devices
- Market Cap
- $299.25M
- P/E
- unprofitable
X4 Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $298.43M
Surrozen, Inc.
Healthcare / Biotechnology
- Market Cap
- $297.60M
- P/E
- unprofitable
Benitec Biopharma Inc.
Healthcare / Biotechnology
- Market Cap
- $295.11M
- P/E
- unprofitable
Profound Medical Corp.
Healthcare / Medical Devices
- Market Cap
- CA$293.42M
- P/E
- unprofitable
Century Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $291.53M
- P/E
- unprofitable
Prelude Therapeutics Incorporated
Healthcare / Biotechnology
- Market Cap
- $291.28M
- P/E
- unprofitable
Agenus Inc.
Healthcare / Biotechnology
- Market Cap
- $289.04M
- P/E
- 2.5
Cabaletta Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $286.53M
- P/E
- unprofitable
Fulcrum Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $282.61M
- P/E
- unprofitable
InfuSystem Holdings, Inc.
Healthcare / Medical Devices
- Market Cap
- $279.84M
- P/E
- 35.1
Ocugen, Inc.
Healthcare / Biotechnology
- Market Cap
- $276.41M
- P/E
- unprofitable
Anika Therapeutics, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $275.69M
- P/E
- unprofitable
Treace Medical Concepts, Inc.
Healthcare / Medical Devices
- Market Cap
- $269.24M
- P/E
- unprofitable
Quantum-Si incorporated
Healthcare / Medical Devices
- Market Cap
- $269.23M
- P/E
- unprofitable
Showing 501–550 of 1,092 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.